Adalimumab, a Tumor Necrosis Factor Blockade Therapy,...

Clinical Immunology 2010 Vol. 135; Iss. supp-S

Adalimumab, a Tumor Necrosis Factor Blockade Therapy, Decreases Th1 and Th17 Populations in Rheumatoid Arthritis Patients

Barbara Pesce, Diego Catalan, Natalia Orrego, Octavio Aravena, Lilian Soto, Pamela Wurman, Francisca Sabugo, Miguel Cuchacovich, Juan Aguillon
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
135
Year:
2010
Language:
english
Pages:
1
DOI:
10.1016/j.clim.2010.03.316
File:
PDF, 43 KB
english, 2010
Conversion to is in progress
Conversion to is failed